Clifford Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$2.95M |
| 2 |
Perdoceo Education
PRDO
|
+$1.18M |
| 3 |
WesBanco
WSBC
|
+$398K |
| 4 |
NXGN
NextGen Healthcare, Inc. Common Stock
NXGN
|
+$373K |
| 5 |
NCR Voyix
VYX
|
+$345K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTB
Cooper Tire & Rubber Co.
CTB
|
+$3.83M |
| 2 |
CIT
CIT Group Inc.
CIT
|
+$306K |
| 3 |
CHS
Chicos FAS, Inc.
CHS
|
+$243K |
| 4 |
Hancock Whitney
HWC
|
+$148K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.48% |
| 2 | Technology | 21.98% |
| 3 | Consumer Discretionary | 13.97% |
| 4 | Consumer Staples | 11.42% |
| 5 | Industrials | 11.28% |
Similar funds
Clifford Capital Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Clifford Capital Partners held 44 positions worth $107M, up 11% from $96.2M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Clifford Capital Partners deployed $6.39M of net new capital in Q2 2021, opening 4 new positions and adding to 36 existing holdings. Its largest new stake was Cardinal Health: 50,476 shares worth $2.88M.
By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was CIT Group Inc., an estimated $306K trimmed.
- Clifford Capital Partners's largest Q2 2021 buy was Cardinal Health: 50,476 shares worth $2.88M.
- Clifford Capital Partners added most to Perdoceo Education in Q2 2021, an estimated $1.18M increase.
- Clifford Capital Partners's biggest Q2 2021 reduction was CIT Group Inc., cutting an estimated $306K.
- Clifford Capital Partners fully exited Cooper Tire & Rubber Co. in Q2 2021, selling an estimated $3.83M.
- Clifford Capital Partners's ten largest holdings make up 40% of its $107M portfolio in Q2 2021.
- Clifford Capital Partners opened 4 new positions and closed 1 in Q2 2021.
- Clifford Capital Partners's portfolio value rose 11% quarter-over-quarter to $107M.
Based on Clifford Capital Partners's 13F filing for Q2 2021, filed 13 Aug 2021.